Log in
Pharmacology · Cardiovascular Drugs

Centrally acting antihypertensive drugs

Medamenta antihypertensiva centraliter agentia

Centrally acting antihypertensive drugs lower blood pressure by reducing sympathetic impulses to the heart and blood vessels. They act on structures of the medulla oblongata, decreasing cardiac output and total peripheral vascular resistance.

Localizationmedulla oblongata, nucleus tractus solitarii
ReceptorsI1-imidazoline and alpha2-adrenergic receptors
Drugsmoxonidine, clonidine, methyldopa, guanfacine
Hemodynamicsdecrease in cardiac output and systemic vascular resistance
2 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Anatomical substrate and localization of the effect

The primary level of central regulation of vascular tone is the medulla oblongata. Its rostral and ventrolateral divisions contain the vasoconstrictor center, which includes the C-1 vasoconstrictor zone and the cardioaccelerator zone. The most critical sensory zone here is the nucleus tractus solitarii — nucleus of the solitary tract.

This nucleus processes incoming signals of two types:

  1. Descending impulses from higher CNS centers (cerebral cortex and hypothalamus).
  2. Afferent signals from baroreceptors of the carotid sinus and aortic arch, transmitted via the vagus nerve fibers.

The membranes of the neurons in the nucleus of the solitary tract contain two key targets: I1-imidazoline receptors (their endogenous ligand is agmatine) and alpha2-adrenergic receptors.

Mechanism of action and pharmacological differences of drugs

Centrally acting drugs activate neurons of the nucleus of the solitary tract, triggering a cascade that inhibits the vasomotor center via intercalated interneurons. However, their receptor interactions vary:

  • Moxonidine acts as a selective agonist, selectively stimulating I1-imidazoline receptors.
  • Clonidine and guanfacine exhibit a mixed effect, directly stimulating both I1-receptors and alpha2-adrenergic receptors.
  • Methyldopa is a prodrug. Upon entering the body, it is metabolized into the active metabolite — alpha-methylnoradrenaline, which selectively stimulates alpha2-adrenergic receptors.
Test your knowledge on the topicTasks from the «Pharmacology» course bank — instant answers and explanations.

Efferent pathways and systemic effects

Receptor stimulation within the nucleus of the solitary tract reorganizes the body's autonomic balance in two main directions:

  1. Suppression of sympathetic activity: Inhibitory interneurons suppress the vasoconstrictor center. As a result, descending adrenergic impulses to blood vessels (decreasing SVR), to the heart (reducing heart rate and contractility, dropping cardiac output), and to the kidneys (reducing renin secretion) are diminished.
  2. Activation of parasympathetic activity: The nucleus of the solitary tract excites the vagus nerve nucleus (n. vagus), enhancing cholinergic impulses to the heart and causing bradycardia.

A typical side effect associated with the drop in blood pressure is fluid retention in the body as a compensatory reaction.

Briefly: answers to topical questions

What are the absolute and relative contraindications to prescribing centrally acting antihypertensive drugs?

The available materials describe only specific restrictions for individual centrally acting antihypertensive agents.

  • Clonidine and guanfacine — driving is contraindicated during their intake, as these drugs cause drowsiness, lethargy, and slowed reaction time.
  • Methyldopa — not recommended for prescription in the postpartum period due to an increased risk of postpartum depression.

General absolute contraindications for the entire group of drugs are not specified.

How to memorize

"Methyldopa masquerades as a metabolite (alpha-methylnoradrenaline), while moxonidine hits I1 directly."

Class and exam questions

What is the main anatomical center responsible for the action of these drugs?

The main anatomical substrate is the medulla oblongata, specifically the nucleus of the solitary tract (nucleus tractus solitarii), where the target receptors are localized.

What is the pharmacodynamic feature of methyldopa?

Methyldopa is a prodrug. In the body, it is converted into the active metabolite — alpha-methylnoradrenaline, which selectively stimulates alpha2-adrenergic receptors.

Which hemodynamic parameters decrease under the influence of these agents?

The reduction in sympathetic impulses leads to a simultaneous decrease in two main parameters: cardiac output and total peripheral vascular resistance (SVR).

Confused? Ask the AIThe AI tutor has reviewed the material on "Centrally Acting Antihypertensive Drugs" and will explain it in simple terms.

What else to study on this topic

  • Structure of the vasoconstrictor center in the rostral and ventrolateral divisions of the medulla oblongata
  • The role of agmatine as an endogenous ligand for I1-imidazoline receptors
  • The involvement of inhibitory interneurons in signal transmission from the nucleus of the solitary tract
  • The effect of central sympatholytics on renin secretion in the kidneys
  • Mechanisms of fluid retention development as a side effect of antihypertensive therapy

Master the entire topic in the «Pharmacology» course

This is a summary. The course covers everything tested in classes and exams.

  • Comprehensive study guide on "Centrally Acting Antihypertensive Drugs" and 5,304 more pages of the subject
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 116 video lessons on the subject

Other topics in the section "Cardiovascular Drugs"

The entire section "Cardiovascular Drugs"

Free video lessons: pharmacologyShort lessons with study notes — no registration required.

Watch lessons

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.